24
Views
5
CrossRef citations to date
0
Altmetric
Research Article

A double-blind, parallel trial of oxaprozin versus naproxen in the treatment of osteoarthritis

&
Pages 689-695 | Received 17 Nov 1983, Published online: 11 Aug 2008

References

  • Ballard E, Walker B., Gold J. A multicentre comparison of oxaprozin and aspirin therapy in rheumatoid arthritis. Clin. Pharmacol. Ther. 1978; 23: 1081. Ballard E, Walker B., Gold J. A multicentre comparison of oxaprozin and aspirin therapy in rheumatoid arthritis. Clin. Pharmacol. Ther. 1978; 23: 108
  • Conover W. “Practical Non-parametric Statistics”. Wiley, New York 19712. Conover W. “Practical Non-parametric Statistics”. Wiley, New York 1971
  • Jamar R., Dequeker J. Oxaprozin versus naproxen in rheumatoid arthritis. Curr. Med. Res. Opin. 1978; 5: 4333. Jamar R., Dequeker J. Oxaprozin versus naproxen in rheumatoid arthritis. Curr. Med. Res. Opin. 1978; 5: 433
  • Janssen E, Jusko W., Chiang S., Kirkman S., Southgate P., Coleman A., Ruelius H. Metabolism and kinetics of oxaprozin in normal subjects. Clin. Pharmacol. Ther. 1980; 25: 3524. Janssen E, Jusko W., Chiang S., Kirkman S., Southgate P., Coleman A., Ruelius H. Metabolism and kinetics of oxaprozin in normal subjects. Clin. Pharmacol. Ther. 1980; 25: 352
  • Mantel N. Chi-square tests with one degree of freedom. J. Am. Statist. Assoc. 1963; 58: 6905. Mantel N. Chi-square tests with one degree of freedom. J. Am. Statist. Assoc. 1963; 58: 690
  • Rosenthale M., Begany A., Dervinis A., Malis J., Shriver D., Dakto L., Gluckman M. Anti-inflammatory properties of 4,5 diphenyl-2-oxazole propionic acid. Agents Actions 1974; 4: 1516. Rosenthale M., Begany A., Dervinis A., Malis J., Shriver D., Dakto L., Gluckman M. Anti-inflammatory properties of 4,5 diphenyl-2-oxazole propionic acid. Agents Actions 1974; 4: 151
  • Snedecor G., Cochran W. “Statistical Methods”. Iowa State University Press, Iowa 19807. Snedecor G., Cochran W. “Statistical Methods”. Iowa State University Press, Iowa 1980

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.